Stay updated on VX-809 and VX-770 in CF Clinical Trial
Sign up to get notified when there's something new on the VX-809 and VX-770 in CF Clinical Trial page.

Latest updates to the VX-809 and VX-770 in CF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section updated with additional sites across many US states and international locations (including Rhone and Thuringia) and several sites removed. The HHS Vulnerability Disclosure entry was removed.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page footer now shows a new revision number: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

- Check42 days agoChange DetectedMinor text updates to the Publications section: a note that publications are auto-filled from PubMed and a revision note (v3.3.1) were added, while the previous PubMed description (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding-status notice about government funding lapse has been removed from the study details page.SummaryDifference0.2%

- Check63 days agoChange DetectedThe two screenshots show the same study details page with core sections in the same order; only minor visual differences are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to VX-809 and VX-770 in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-809 and VX-770 in CF Clinical Trial page.